Digital image analysis of Ki67 hotspot detection and index counting in gastroenteropancreatic neuroendocrine neoplasms

被引:1
作者
Saetiew, Kritsanu [1 ,2 ]
Angkathunyakul, Napat [2 ]
Hunnangkul, Saowalak [3 ]
Pongpaibul, Ananya [2 ]
机构
[1] Srinakharinwirot Univ, Panyananthaphikkhu Chonprathan Med Ctr, Dept Anat Pathol, Bangkok, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, 2 Wanglang Rd, Bangkok 10700, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand
关键词
Ki-67 proliferative index; Neuroendocrine tumor; Gastrointestinal neuroendocrine neoplasms; Hotspot selection; Gradient map visualization; Digital image analysis; QUANTIFICATION; GUIDELINES; TUMORS;
D O I
10.1016/j.anndiagpath.2024.152295
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The Ki-67 proliferative index plays a pivotal role in the subclassification of neuroendocrine neoplasm (NEN) according to the WHO Classification of Digestive System Tumors (5th edition), which designates neuroendocrine tumor (NET) grades 1, 2, and 3 for Ki-67 proliferative index of <3 %, 3-20 %, and >20 %, respectively. Proliferative index calculation must be performed in the hotspot, traditionally selected by visual scanning at low-power magnification. Recently, gradient map visualization has emerged as a tool for various purposes, including hotspot selection. This study includes 97 cases of gastrointestinal neuroendocrine neoplasms, with hotspots selected by bare eye and gradient map visualization (GM). Each hotspot was analyzed using three methods: eye estimation (EE), digital image analysis (DIA), and manual counting. Of the NENs studied, 91 % were NETs (26 % for G1, 55 % for G2, and 10 % for G3). Only 9 cases were neuroendocrine carcinoma (NEC). Between two hotspot selection methods, GM resulted in a higher grade in 14.77 % of cases, primarily upgrading from NET G1 to G2. Among the counting methods, DIA demonstrated substantial agreement with manual counting, both for pathologist and resident. Grading by other methods tended to result in a higher grade than MC (26.99 % with EE and 8.52 % with DIA). Given its clinical and statistical significance, this study advocates for the application of GM in hotspot selection to identify higher-grade tumors. Furthermore, DIA provides accurate grading, offering time efficiency over MC.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] The Ki67 index evaluation of pancreatic neuroendocrine tumors using 3D immunohistochemistry in small tissue specimens
    Ikeda, Eriko
    Shinozaki, Satoshi
    Sakaguchi, Mio
    Sano, Naoki
    Kabasawa, Shin
    Kanno, Atsushi
    Ando, Kozue
    Yokoyama, Kensuke
    Tamada, Kiichi
    Onodera, Hiroshi
    Yamamoto, Hironori
    Fukushima, Noriyoshi
    PANCREATOLOGY, 2023, 23 (05) : 537 - 542
  • [42] How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? A meta-analysis
    Li, Jun
    Lin, Jin Ping
    Shi, Liu Hong
    Wang, Wei Jia
    Li, Ai Qing
    Si, Jian Min
    Chen, Shu Jie
    JOURNAL OF DIGESTIVE DISEASES, 2016, 17 (02) : 95 - 103
  • [43] A Ki-67 Index to Predict Treatment Response to the Capecitabine/Temozolomide Regimen in Neuroendocrine Neoplasms: A Retrospective Multicenter Study
    Wang, Wei
    Zhang, Yu
    Peng, Ying
    Jin, Kai-Zhou
    Li, Yuan-Liang
    Liang, Yao
    Tan, Huang-Ying
    Yu, Xian-Jun
    Zhou, Zhi-Wei
    Chen, Jie
    NEUROENDOCRINOLOGY, 2021, 111 (08) : 752 - 763
  • [44] Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
    McCall, Chad M.
    Shi, Chanjuan
    Cornish, Toby C.
    Klimstra, David S.
    Tang, Laura H.
    Basturk, Olca
    Mun, Liew Jun
    Ellison, Trevor A.
    Wolfgang, Christopher L.
    Choti, Michael A.
    Schulick, Richard D.
    Edil, Barish H.
    Hruban, Ralph H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (11) : 1671 - 1677
  • [45] Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement
    Koopman, Timco
    Buikema, Henk J.
    Hollema, Harry
    de Bock, Geertruida H.
    van der Vegt, Bert
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (01) : 33 - 42
  • [46] The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence
    Marchevsky, Alberto M.
    Hendifar, Andrew
    Watts, Ann E.
    MODERN PATHOLOGY, 2018, 31 (10) : 1523 - 1531
  • [47] Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis
    Naheed, Salma
    Holden, Chloe
    Tanno, Lulu
    Pattini, Linda
    Pearce, Neil W.
    Green, Bryan
    Jaynes, Eleanor
    Cave, Judith
    Ottensmeier, Christian H.
    Pelosi, Giuseppe
    BMJ OPEN, 2022, 12 (03):
  • [48] Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
    Yang, Zhaohai
    Tang, Laura H.
    Klimstra, David S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (06) : 853 - 860
  • [49] New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas
    Grala, Bartlomiej
    Markiewicz, Tomasz
    Kozlowski, Wojciech
    Osowski, Stanislaw
    Slodkowska, Janina
    Papierz, Wielislaw
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2009, 47 (04) : 587 - 592
  • [50] Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms
    Pyo, Jung-Soo
    Kim, Nae Yu
    Min, Kyueng-Whan
    Oh, Il Hwan
    Lim, Dae Hyun
    Son, Byoung Kwan
    DIAGNOSTICS, 2023, 13 (17)